The study only randomised two patients and so could not address the benefits of intravenous immunoglobulin, however they identified several recruitment barriers which would need to be overcome in future trials
http://ift.tt/2sQOay0
Τετάρτη 28 Ιουνίου 2017
A multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin compared with standard therapy for the treatment of transverse myelitis in adults and children (STRIVE).
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου